Kim lab
We are advancing a transformative exosome-based therapeutic platform that combines natural targeting capabilities with innovative drug delivery strategies. Through multidisciplinary collaborations spanning pharmaceutical sciences, cancer biology, and immunology, we seek to translate engineered extracellular vesicles into clinically impactful therapies for patients with unmet medical needs.